MetLife MET
- Market cap
- $62.8B
- PE
- 18.9×
- 10y median 13.3×
- Forward PE
- 9.2×
- 10y median 9.0×
- Price to sales
- 0.8×
- Revenue, 12 months
- $79.4B
- +9% on a year ago
- Net margin
- 4.6%
MetLife trades at 18.9× trailing earnings, pricier than 74% of the last ten years. Revenue was $79.4B over the last twelve months, up 9% on a year earlier with a 5% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $15.9B−29% | $19B+22% | $16.1B+4% | $17.8B+7% | $18.4B+16% | $18.7B−2% | $18.6B+16% | $17.3B−3% | $17.4B−6% | $23.8B+28% | $19.1B+3% | $19.2B+11% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $534M−62% | $941M−54% | $1B+307% | $1.2B+180% | $2B+273% | $1.4B+47% | $1.4B+30% | $980M−19% | $1.2B−39% | $1.1B−19% | $1.5B+11% | $1B+6% |
| $39M−84% | $327M−27% | $170M−1% | $249M+1032% | $653M+1574% | $106M−68% | $404M+138% | $245M−2% | $308M−53% | $301M+184% | $345M−15% | $256M+5% | |
| Net income | $489M−58% | $607M−62% | $867M+984% | $946M+135% | $1.3B+174% | $1.3B+109% | $945M+9% | $729M−23% | $896M−33% | $809M−36% | $1.2B+25% | $736M+1% |
| $0.56−59% | $0.77−61% | $1.10+5400% | $1.28+167% | $1.81+223% | $1.78+131% | $1.28+16% | $1.03−20% | $1.22−33% | $1.17−34% | $1.74+36% | $1.09+6% | |
| 755.5M−6% | 743.3M−6% | 728.4M−7% | 714.7M−7% | 703.7M−7% | 698M−6% | 687M−6% | 675M−6% | 669.1M−5% | 662.3M−5% | 655.7M−5% | 646.9M−4% |
EPS, diluted: Q4 FY08 and Q4 FY09: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'. 4 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 3 periods, Q2 FY08 to Q1 FY09: not printed by the filing, worked out from its own lines. 16 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY16: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $19.9B | $19B to $20.4B | $2.77 | $2.66 to $2.91 | 12 |
| Q4 FY26 | $20.7B | $20.2B to $21.4B | $2.63 | $2.53 to $2.67 | 10 |
| Q1 FY27 | $20.5B | $19.9B to $21.1B | $2.57 | $2.48 to $2.68 | 8 |
| Q2 FY27 | $20.6B | $20B to $21.3B | $2.81 | $2.71 to $2.92 | 8 |
| Q3 FY27 | $20.8B | $20.2B to $21.5B | $2.85 | $2.74 to $2.96 | 8 |
| Q4 FY27 | $21.3B | $20.7B to $22B | $2.90 | $2.79 to $3.01 | 8 |
| Q1 FY28 | $21.7B | $21B to $22.3B | $2.87 | $2.77 to $2.98 | 9 |
| Q2 FY28 | $21.9B | $21.3B to $22.6B | $3.08 | $2.97 to $3.20 | 9 |
Peers
Companies in Insurance - Life nearest MetLife's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| METMetLife | $62.8B | 18.9× | 13.3× | 9.2× | 0.8× | +9% | 4.6% |
| AFLAflac | $60.4B | 12.9× | 10.5× | 16.4× | 3.3× | +14% | 26.9% |
| PRUPrudential Financial | $39.7B | 10.4× | 10.9× | 8.3× | 0.6× | +9% | 6.0% |
| RGAReinsurance Group of America | $17.2B | 11.6× | 12.5× | n/m | 0.7× | +19% | 5.8% |
| CRBGCorebridge Financial | $15.2B | 19.8× | 9.8× | n/m | 0.8× | +29% | 4.5% |
| UNMUnum | $14.3B | 21.0× | 8.0× | n/m | 1.1× | +3% | 5.3% |
| GLGlobe Life | $11.9B | 10.3× | 13.0× | n/m | 1.9× | +5% | 19.6% |
| JXNJackson Financial | $8.8B | 183× | 7.6× | n/m | 1.4× | +15% | 1.6% |
| VOYAVoya Financial | $8.7B | 16.2× | 11.9× | n/m | 1.1× | +3% | 7.4% |
| PRIPrimerica | $8.4B | 11.0× | 15.0× | n/m | 2.5× | +9% | 23.2% |
| LNCLincoln National | $7.6B | 3.5× | 9.3× | n/m | 0.4× | +8% | 12.2% |
| Peer median | $13.1B | 12.2× | 10.7× | 12.3× | 1.1× | +9% | 6.7% |
More on MetLife
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Profit margin
- Shares outstanding
Where it ranks
- #6of 69Financial stocks with the lowest forward PE
- #8of 17Life insurers with the fastest revenue growth
- #9of 17Life insurers with the lowest price to sales ratio
- #6of 10Life insurers cheapest against their own PE history
Its groups
About
- Industry
- Insurance - Life
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .